Continuous Manufacturing Research Act of 2021
This bill adds advanced pharmaceutical manufacturing as a research area that may be supported under the National Science Foundation's manufacturing research grant program.
To improve support for research and development of advanced 
         pharmaceutical manufacturing techniques and workforce.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Continuous Manufacturing Research 
Act of 2021''.

SEC. 2. RESEARCH ON ADVANCED PHARMACEUTICAL MANUFACTURING.

    Section 506(a) of the America COMPETES Reauthorization Act of 2010 
(42 U.S.C. 1862p-1(a)) is amended--
            (1) in paragraph (5), by striking ``and'' at the end;
            (2) in paragraph (6), by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(7) advanced pharmaceutical manufacturing fundamental and 
        translational research, including--
                    ``(A) continuous manufacturing of drugs and 
                biological products; and
                    ``(B) similar innovative monitoring and control 
                techniques.''.
                                 <all>
Continuous Manufacturing Research Act of 2021
To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce.
Continuous Manufacturing Research Act of 2021
Rep. Spanberger, Abigail Davis